Get started
Author

Cristina Tomarchio

Observed names: C. Tomarchio, CRISTINA TOMARCHIO
ORCID: 0000-0002-1044-1008
Observed ORCID: 0000-0002-1044-1008
OpenAlex ID: A5083416640
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
2021 · Elena Tirrò, Michele Massimino, et al. · Frontiers in Oncology · 44
PDF
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
2020 · MICHELE MASSIMINO, STEFANIA STELLA, et al. · Anticancer Research · 36
PDF
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
2021 · Chiara Romano, Federica Martorana, et al. · International Journal of Molecular Sciences · 30
PDF
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
2021 · Stefania Stella, Michele Massimino, et al. · International Journal of Molecular Sciences · 22
PDF
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer
2023 · Michele Massimino, Federica Martorana, et al. · Genes · 19
PDF
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
2021 · Michele Massimino, Elena Tirrò, et al. · Frontiers in Pharmacology · 17
PDF
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients
2024 · Stefania Stella, Silvia Rita Vitale, et al. · Genes · 9
Optimal Response in a Patient With CML Expressing BCR–ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report
2020 · LIVIA MANZELLA, ELENA TIRRÒ, et al. · In Vivo · 7
PDF
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability
2023 · Michele Massimino, Stefania Stella, et al. · OncoTargets and Therapy · 4
PDF
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients
2022 · Stefania Stella, Silvia Vitale, et al. · Diagnostics · 4
PDF
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic
2021 · Stefania Stella, Silvia Rita Vitale, et al. · Diagnostics · 4
PDF
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level
2025 · Fabio Stagno, Stefania Stella, et al. · International Journal of Molecular Sciences · 3
PDF
The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness
2025 · Michele Massimino, Stefania Stella, et al. · International Journal of Molecular Sciences · 2
PDF
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model
2026 · Andrea Duminuco, Silvia Rita Vitale, et al. · Genes · 1
PDF
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
2025 · Michele Massimino, Elena Tirrò, et al. · Biomolecules · 1
PDF
Revisiting diffuse gliomas in the era of precision medicine: Molecular insights and therapeutic implications
2026 · Michele Massimino, Stefania Stella, et al. · Critical Reviews in Oncology/Hematology
Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review
2026 · Silvia R. Vitale, Melissa Drago, et al. · Pharmaceutics
PDF
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs
2026 · Michele Massimino, Elena Tirrò, et al. · Frontiers in Pharmacology
PDF
Works count: 19
Citation count: 203
H-index: 7
I10-index: 6
Year
Topic
Type